The supply and demand environment continues to improve, and medical equipment leads to continue to benefit from import substitution.

Medical Network November 1st The National Health and Health Commission recently released the "2018-2020 Large Medical Equipment Configuration Plan" proposed that by the end of 2020, the country plans to allocate 22,548 large-scale medical equipment, including 10,097 units, which will be implemented in three years. Among them, the national master plan configuration of the proton therapy tumor system is controlled within 10 sets, all of which are newly added; the positron emission tomography system (PET/MR) has a temporary provisional configuration of 33 units, including 28 new ones; Planning and configuration of 197 units, including 154 new.

In recent years, China's urbanization and aging trend has continued to accelerate, and the demand for medical device equipment has also achieved rapid growth. In 2017, China's medical device market was about 458.3 billion yuan, and the compound growth rate of industry scale reached 24% in the past 10 years. In respect, the current development of China's medical device market still lags behind drug In the market, the scale of China's equipment/drug market is only 0.2:1, far below the global level of 0.5:1, and the potential for future space is huge. The agency predicts that the growth center of China's medical equipment industry will remain at 15-20% in the next five years. about.

Judging from the industry pattern, China's equipment industry currently presents a small and scattered competition pattern. In the 16,000 equipment manufacturing enterprises, most of them are small in scale, and the average industry income is 23 million yuan. In contrast, in 2016. global medical instruments In the $387 billion market, the top ten enterprise Sales totaled US$145.3 billion, with a total market share of 37.55%. Medtronic is the leader in equipment, with sales of US$29.7 billion, maintaining a steady growth of around 3% per year, accounting for 8% of the global market share. It can be seen that it is developed with Europe and the United States. Compared with the country, China's medical device industry still has great potential for development.

Benefiting from the continuous improvement of the policy environment, China's medical device industry is facing a good development opportunity. Since 2014, the progress of policy introduction in related fields has accelerated significantly, especially with the gradual landing of graded diagnosis and treatment policies, the demand for medical equipment in the grassroots market continues to be fast. Growth. In the first half of this year, the National Health and Health Commission also issued a catalogue of large-scale medical equipment configuration license management (2018), which greatly reduced the list of equipment that the National Health and Health Commission had to purchase. The proposed large-scale medical equipment configuration plan involved The huge number of equipments further reflects the state's support for the high-end medical device industry. In the future, with the continuous improvement of the efficiency of the medical device approval process, the speed of listing innovative medical device equipment is expected to be greatly accelerated, and the industry's supply shortage will improve. The equipment industry is expected to usher in the spring.

From the perspective of China's medical device market structure, high-end products such as color ultrasound, optical ray, medical X-ray, high-end interventional materials and diagnostic or test reagents account for 44.3% of China's total medical device imports. Under the policy support trend, high-quality domestic medical equipment may accelerate the process of import substitution. The import substitution space in these areas is very considerable. Among listed companies, Mindray Medical, Lanfan Medical and Lepu Medical are expected to continue to benefit from the domestic import substitution process. accelerate.